Bladder cancer treatment showdown: which chemo works better?
NCT ID NCT01812369
Summary
This study compared two different chemotherapy combinations for people with advanced bladder cancer who need treatment before or after bladder removal surgery. Researchers tested whether a more intensive four-drug combination (HD-MVAC) works better than the standard two-drug combination (GC) at keeping cancer from returning. The trial involved 500 participants and measured how long patients remained cancer-free after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UHRouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.